Search results for "non-response"

showing 6 items of 6 documents

Improving predictive accuracy of exit polls

2010

Abstract Exit polls are best known for their use in election forecasting. In recent years, however, some prominent mistaken predictions have been made, undermining public confidence in the accuracy of both exit polls and survey methods. Nonresponse bias has been claimed as being one of the main reasons for inaccurate projections. Traditionally, the issue has been handled through an age–race–sex adjustment at the national and state levels. An alternative solution is suggested and detailed in this paper. A two-step strategy is proposed to reduce nonresponse bias and improve predictions. First, “vote-remembering” (vote recall) is used to correct party proportion estimates at polling locations;…

Survey methodologyComputer scienceVotingmedia_common.quotation_subjectPrecinctPublic confidenceEconometricsSurvey samplingNon-response biasBusiness and International ManagementPollingRaw datamedia_commonInternational Journal of Forecasting
researchProduct

Encuestas a pie de urna en España. ¿Error muestral o sesgo de no respuesta?

2016

Countless examples of misleading forecasts on behalf of both pre-election and exit polls can be found all over the world. Non-representative samples due to differential nonresponse have been claimed as being the main reason for inaccurate exit-poll projections. In real inference problems, it is seldom possible to compare estimates and true values. Electoral forecasts are an exception. Comparisons between estimates and final outcomes can be carried out once votes have been tallied. In this paper, we examine the raw data collected in seven exit polls conducted in Spain and test the likelihood that the data collected in each sampled voting location can be considered as a random sample of actua…

Spanish regional electionsmedia_common.quotation_subjectlcsh:HM401-1281InferenceContext (language use)01 natural sciencesPredicciones en la noche electoral010104 statistics & probabilityElecciones regionales españolasnonresponseVoting050602 political science & public administrationEconometricsEconomicsNon-response biasQuality (business)0101 mathematicsNo-respuestamedia_commonElection night forecasts05 social sciencesGeneral Social SciencesDifferential (mechanical device)Error de medida0506 political scienceTest (assessment)lcsh:Sociology (General)Distribución multi-hipergeométricaRaw datameasurement errormulti-hypergeometric distributionRevista Internacional de Sociología
researchProduct

Selection bias was reduced by recontacting nonparticipants

2016

Objective One of the main goals of health examination surveys is to provide unbiased estimates of health indicators at the population level. We demonstrate how multiple imputation methods may help to reduce the selection bias if partial data on some nonparticipants are collected. Study Design and Setting In the FINRISK 2007 study, a population-based health study conducted in Finland, a random sample of 10,000 men and women aged 25–74 years were invited to participate. The study included a questionnaire data collection and a health examination. A total of 6,255 individuals participated in the study. Out of 3,745 nonparticipants, 473 returned a simplified questionnaire after a recontact. Both…

Research designAdultMaleBiomedical Researchbiasmultiple imputationEpidemiologyCross-sectional studymedia_common.quotation_subjectPopulation01 natural sciencesProxy (climate)010104 statistics & probability03 medical and health sciencesmissing data0302 clinical medicinenon-responseStatisticsHumanssurvey030212 general & internal medicine0101 mathematicseducationFinlandSelection Biasmedia_commonAgedResponse rate (survey)Selection biasAged 80 and overeducation.field_of_studyta112Patient Selectionta3142Middle AgedMissing dataHealth indicatorCross-Sectional StudiesResearch DesignFemalePsychologyDemographyFollow-Up Studies
researchProduct

Systematic handling of missing data in complex study designs : experiences from the Health 2000 and 2011 Surveys

2016

We present a systematic approach to the practical and comprehensive handling of missing data motivated by our experiences of analyzing longitudinal survey data. We consider the Health 2000 and 2011 Surveys (BRIF8901) where increased non-response and non-participation from 2000 to 2011 was a major issue. The model assumptions involved in the complex sampling design, repeated measurements design, non-participation mechanisms and associations are presented graphically using methodology previously defined as a causal model with design, i.e. a functional causal model extended with the study design. This tool forces the statistician to make the study design and the missing-data mechanism explicit…

Statistics and Probabilitymultiple imputationComputer sciencecomputer.software_genre01 natural sciences010104 statistics & probability03 medical and health sciences0302 clinical medicinenon-responseSampling design030212 general & internal medicine0101 mathematicsCausal modelta112Clinical study designInverse probability weightingSampling (statistics)non-participationMissing dataData sciencedoubly robust methodsSurvey data collectionData miningStatistics Probability and Uncertaintycomputerinverse probability weightingStatisticiancausal model with designJournal of Applied Statistics
researchProduct

Non-response bias as a likely cause of the association between young maternal age at the time of delivery and the risk of cancer in the offspring.

2003

Some epidemiological studies have shown an association between young maternal age at the time of delivery and risk of cancer in the offspring. In a recent German case-control study, there was a twofold increase in the leukaemia risk for children whose mothers were aged < 20 years at the time of delivery. As the prevalence of younger mothers among control families was particularly low, data on maternal age distributions for the general population of Germany were obtained in order to examine the representativeness of the control sample. Despite the excellent sampling frame based on data from complete and up-to-date population registries and a satisfactory response rate among controls ( approx…

RiskPediatricsmedicine.medical_specialtyEpidemiologyOffspringPopulationCentral Nervous System NeoplasmsNeuroblastomaBiasEpidemiologyMedicineHumansNon-response biaseducationSampling frameResponse rate (survey)education.field_of_studybusiness.industryLymphoma Non-HodgkinCase-control studyInfant NewbornPrecursor Cell Lymphoblastic Leukemia-LymphomaSample size determinationCase-Control StudiesSample SizePediatrics Perinatology and Child HealthFemalebusinessDemographyMaternal AgePaediatric and perinatal epidemiology
researchProduct

Cost effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C.

2013

Background & Aims Randomised controlled trials (RCTs) show that triple therapy (TT) with peginterferon alfa, ribavirin, and boceprevir (BOC) or telaprevir (TVR) is more effective than peginterferon-ribavirin dual therapy (DT) in the treatment of genotype 1 (G1) chronic hepatitis C (CHC) patients with previous relapse (RR), partial response (PAR), and null-response (NR). We assess the cost-effectiveness of TT compared to no therapy in the treatment of patients previously treated with G1 CHC. Methods The available published literature provided the data source. The target population was made up of previously treated Caucasian patients with G1 CHC and these were evaluated over a lifetime horizo…

MaleTVRCost effectivenessCost-Benefit AnalysisPIPeginterferon-alfaBOCHepacivirusBOC Boceprevir CHC Cost-effectiveness DT G1 ICER NR PAR PI PegIFN RBV RR TVR Telaprevir boceprevir chronic hepatitis C dual therapy genotype 1 incremental cost-effectiveness ratio non-response partial response pegylated interferon protease inhibitors relapse ribavirin telaprevirTelaprevirTelaprevirchemistry.chemical_compoundPegylated interferonnon-responseboceprevirincremental cost-effectiveness ratioRBVTreatment FailureDThealth care economics and organizationsRandomized Controlled Trials as Topicrelapsecost effectivenessICERMiddle AgedMarkov ChainsModels EconomicItalyQuality-Adjusted Life YearsSettore SECS-P/02 - politica economicaSettore SECS-S/01 - StatisticaIncremental cost-effectiveness ratioOligopeptidesmedicine.drugmedicine.medical_specialtyGenotypeProlineribavirinSettore MED/12 - GASTROENTEROLOGIAprotease inhibitorsNRRRAntiviral AgentsInternal medicineBoceprevirG1medicineHumanschronic hepatitis Cpegylated interferongenotype 1Hepatologybusiness.industryRibavirindual therapyHepatitis C ChronicQuality-adjusted life yearSurgeryCHCPegIFNchemistryCost-effectivenesspartial responsebusinessPAR
researchProduct